DocMorris Board Urges Shareholders to Block ‘Creeping Takeover’ at May General Meeting

DocMorris ( (CH:DOCM) ) has shared an announcement.

DocMorris has published the invitation to its 12 May General Meeting, where a partial renewal of the six-member Board of Directors will dominate the agenda amid a governance battle with minority shareholder CEPD N.V. The board is proposing three independent candidates – Thomas Bucher, Nicole Formica-Schiller and Thomas Reutter – citing their financial, AI and corporate-governance expertise to support the company’s next growth phase and preserve its recently affirmed strategic momentum.

In parallel, the board is urging shareholders to reject CEPD’s rival slate of three directors and a bid for the chairmanship by Polish investor Jacek Szwajcowski, arguing this would amount to a creeping takeover that concentrates control in a 15% shareholder without a formal premium-bearing bid. Emphasising loyalty and due-care obligations to all investors, the board frames the vote as pivotal to safeguarding DocMorris’s independence, strategic continuity and long-term value creation, and calls on shareholders to register and exercise their voting rights.

The most recent analyst rating on (CH:DOCM) stock is a Sell with a CHF3.50 price target. To see the full list of analyst forecasts on DocMorris stock, see the CH:DOCM Stock Forecast page.

More about DocMorris

Swiss-based DocMorris AG operates in digital healthcare, focusing on online pharmacy, telemedicine and health-product marketplaces across Germany and other European markets. Orders are mainly fulfilled from a highly automated logistics hub in Heerlen, Netherlands, and the group also runs TeleClinic, Germany’s largest telemedicine platform, and leading health marketplaces in Southern Europe.

Average Trading Volume: 288,501

Technical Sentiment Signal: Sell

Current Market Cap: CHF270.8M

See more data about DOCM stock on TipRanks’ Stock Analysis page.